Terminal digit preference: a source of measurement error in breast cancer diameter reporting
dc.contributor.author | Tsuruda, Kaitlyn | |
dc.contributor.author | Hofvind, Solveig | |
dc.contributor.author | Akslen, Lars A. | |
dc.contributor.author | Hoff, Solveig Roth | |
dc.contributor.author | Veierød, Marit Bragelien | |
dc.date.accessioned | 2019-10-01T07:56:56Z | |
dc.date.accessioned | 2019-10-14T08:46:57Z | |
dc.date.available | 2019-10-01T07:56:56Z | |
dc.date.available | 2019-10-14T08:46:57Z | |
dc.date.issued | 2019-09-14 | |
dc.identifier.citation | Tsuruda M, Hofvind S, Akslen LA, Hoff Sr, Veierød MB. Terminal digit preference: a source of measurement error in breast cancer diameter reporting. Acta Oncologica. 2019 | en |
dc.identifier.issn | 0284-186X | |
dc.identifier.issn | 0284-186X | |
dc.identifier.issn | 1651-226X | |
dc.identifier.uri | https://hdl.handle.net/10642/7661 | |
dc.description.abstract | Objectives: Women diagnosed with breast cancer are offered treatment and therapy based on tumor characteristics, including tumor diameter. There is scarce knowledge whether tumor diameter is accurately reported, or whether it is unconsciously rounded to the nearest half-centimeter (terminal digit preference). This study aimed to assess the precision (number of digits) of breast cancer tumor diameters and whether they are affected by terminal digit preference. Furthermore, we aimed to assess the agreement between mammographic and histopathologic tumor diameter measurements. Material and Methods: This national registry study included reported mammographic and registered histopathologic tumor diameter information from the Cancer Registry of Norway for invasive breast cancers diagnosed during 2012–2016. Terminal digit preference was assessed using histograms. Agreement between mammographic and histopathologic measurements was assessed using the intraclass correlation coefficient (ICC) and Bland-Altman plots. Results: Mammographic, histopathologic, or both tumor measurements were available for 7792, 13,541 and 6865 cases, respectively. All mammographic and 97.2% of histopathologic tumor diameters were recorded using whole mm. Terminal digits of zero or five were observed among 38.7% and 34.8% of mammographic and histopathologic measurements, respectively. There was moderate agreement between the two measurement methods (ICC = 0.52, 95% CI: 0.50–0.53). On average, mammographic measurements were 1.26 mm larger (95% limits of agreement: −22.29–24.73) than histopathologic measurements. This difference increased with increasing tumor size. Conclusion: Terminal digit preference was evident among breast cancer tumor diameters in this nationwide study. Further studies are needed to investigate the potential extent of under-staging and under-treatment resulting from this measurement error. | en |
dc.description.sponsorship | This work was supported by the Norwegian ExtraFoundation for Health and Rehabilitation via the Norwegian Breast Cancer Society under Grant 2018/FO201362 (to Kaitlyn Tsuruda). | en |
dc.language.iso | en | en |
dc.publisher | Taylor and Francis | en |
dc.relation.ispartofseries | Acta Oncologica;Published online 30 Sep 2019 | |
dc.rights | This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. | en |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Terminal digit preferences | en |
dc.subject | Measurements | en |
dc.subject | Breast cancer | en |
dc.subject | Tumors | en |
dc.title | Terminal digit preference: a source of measurement error in breast cancer diameter reporting | en |
dc.type | Journal article | en |
dc.type | Peer reviewed | en |
dc.date.updated | 2019-10-01T07:56:56Z | |
dc.description.version | publishedVersion | en |
dc.identifier.doi | https://dx.doi.org/10.1080/0284186X.2019.1669817 | |
dc.identifier.cristin | 1724940 | |
dc.source.journal | Acta Oncologica |
Files in this item
This item appears in the following Collection(s)
-
HV - Institutt for naturvitenskapelige helsefag [392]
HV - Department of Life Sciences and Health
Except where otherwise noted, this item's license is described as This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.